Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 300

1.

Locoregional recurrence after sentinel lymph node dissection with or without axillary dissection in patients with sentinel lymph node metastases: the American College of Surgeons Oncology Group Z0011 randomized trial.

Giuliano AE, McCall L, Beitsch P, Whitworth PW, Blumencranz P, Leitch AM, Saha S, Hunt KK, Morrow M, Ballman K.

Ann Surg. 2010 Sep;252(3):426-32; discussion 432-3. doi: 10.1097/SLA.0b013e3181f08f32.

PMID:
20739842
[PubMed - indexed for MEDLINE]
2.

Surgical complications associated with sentinel lymph node dissection (SLND) plus axillary lymph node dissection compared with SLND alone in the American College of Surgeons Oncology Group Trial Z0011.

Lucci A, McCall LM, Beitsch PD, Whitworth PW, Reintgen DS, Blumencranz PW, Leitch AM, Saha S, Hunt KK, Giuliano AE; American College of Surgeons Oncology Group.

J Clin Oncol. 2007 Aug 20;25(24):3657-63. Epub 2007 May 7.

PMID:
17485711
[PubMed - indexed for MEDLINE]
Free Article
3.

Axillary dissection vs no axillary dissection in women with invasive breast cancer and sentinel node metastasis: a randomized clinical trial.

Giuliano AE, Hunt KK, Ballman KV, Beitsch PD, Whitworth PW, Blumencranz PW, Leitch AM, Saha S, McCall LM, Morrow M.

JAMA. 2011 Feb 9;305(6):569-75. doi: 10.1001/jama.2011.90.

PMID:
21304082
[PubMed - indexed for MEDLINE]
4.

A 10-year follow-up of treatment outcomes in patients with early stage breast cancer and clinically negative axillary nodes treated with tangential breast irradiation following sentinel lymph node dissection or axillary clearance.

Wernicke AG, Goodman RL, Turner BC, Komarnicky LT, Curran WJ, Christos PJ, Khan I, Vandris K, Parashar B, Nori D, Chao KS.

Breast Cancer Res Treat. 2011 Feb;125(3):893-902. doi: 10.1007/s10549-010-1167-6. Epub 2010 Sep 19.

PMID:
20853176
[PubMed - indexed for MEDLINE]
Free PMC Article
5.

Improved axillary staging of breast cancer with sentinel lymphadenectomy.

Giuliano AE, Dale PS, Turner RR, Morton DL, Evans SW, Krasne DL.

Ann Surg. 1995 Sep;222(3):394-9; discussion 399-401. Review.

PMID:
7677468
[PubMed - indexed for MEDLINE]
Free PMC Article
6.

Prospective observational study of sentinel lymphadenectomy without further axillary dissection in patients with sentinel node-negative breast cancer.

Giuliano AE, Haigh PI, Brennan MB, Hansen NM, Kelley MC, Ye W, Glass EC, Turner RR.

J Clin Oncol. 2000 Jul;18(13):2553-9. Erratum in: J Clin Oncol 2000 Nov 15;18(22):3877.

PMID:
10893286
[PubMed - indexed for MEDLINE]
7.

Sentinel lymph node dissection provides axillary control equal to complete axillary node dissection in breast cancer patients with lobular histology and a negative sentinel node.

Khakpour N, Hunt KK, Kuerer HM, Yi M, Meric-Bernstam F, Ross MI, Lucci A.

Am J Surg. 2005 Oct;190(4):598-601.

PMID:
16164930
[PubMed - indexed for MEDLINE]
8.

Staging of women with breast cancer after introduction of sentinel node guided axillary dissection.

Tvedskov TF.

Dan Med J. 2012 Jul;59(7):B4475. Review.

PMID:
22759850
[PubMed - indexed for MEDLINE]
9.

Should ACOSOG Z0011 change practice with respect to axillary lymph node dissection for a positive sentinel lymph node biopsy in breast cancer?

Giuliano AE, Morrow M, Duggal S, Julian TB.

Clin Exp Metastasis. 2012 Oct;29(7):687-92. doi: 10.1007/s10585-012-9515-z. Epub 2012 Aug 29.

PMID:
22926446
[PubMed - indexed for MEDLINE]
10.

Axillary disease recurrence after sentinel lymph node dissection for breast carcinoma.

Swenson KK, Mahipal A, Nissen MJ, Tuttle TM, Heaton K, Lally RM, Spomer A, Lee MW.

Cancer. 2005 Nov 1;104(9):1834-9.

PMID:
16161037
[PubMed - indexed for MEDLINE]
Free Article
11.

When is a lymph node dissection a lymph node dissection? The number of lymph nodes resected in sentinel and axillary lymph node dissections.

Olaya W, Wong J, Wong J, Morgan J, Kazanjian K, Lum S.

Ann Surg Oncol. 2013 Feb;20(2):627-32. doi: 10.1245/s10434-012-2642-6. Epub 2012 Sep 7.

PMID:
22956069
[PubMed - indexed for MEDLINE]
12.

Axillary dissection is not required for all patients with breast cancer and positive sentinel nodes.

Guenther JM, Hansen NM, DiFronzo LA, Giuliano AE, Collins JC, Grube BL, O'Connell TX.

Arch Surg. 2003 Jan;138(1):52-6.

PMID:
12511150
[PubMed - indexed for MEDLINE]
13.

Completion axillary lymph node dissection not required for regional control in patients with breast cancer who have micrometastases in a sentinel node.

Yegiyants S, Romero LM, Haigh PI, DiFronzo LA.

Arch Surg. 2010 Jun;145(6):564-9. doi: 10.1001/archsurg.2010.84.

PMID:
20566977
[PubMed - indexed for MEDLINE]
14.

Sentinel node skills verification and surgeon performance: data from a multicenter clinical trial for early-stage breast cancer.

Posther KE, McCall LM, Blumencranz PW, Burak WE Jr, Beitsch PD, Hansen NM, Morrow M, Wilke LG, Herndon JE 2nd, Hunt KK, Giuliano AE.

Ann Surg. 2005 Oct;242(4):593-9; discussion 599-602.

PMID:
16192820
[PubMed - indexed for MEDLINE]
Free PMC Article
15.

Impact of the american college of surgeons oncology group Z0011 criteria applied to a contemporary patient population.

Yi M, Kuerer HM, Mittendorf EA, Hwang RF, Caudle AS, Bedrosian I, Meric-Bernstam F, Wagner JL, Hunt KK.

J Am Coll Surg. 2013 Jan;216(1):105-13. doi: 10.1016/j.jamcollsurg.2012.09.005. Epub 2012 Nov 2.

PMID:
23122536
[PubMed - indexed for MEDLINE]
Free PMC Article
16.

National practice patterns of sentinel lymph node dissection for breast carcinoma.

Lucci A Jr, Kelemen PR, Miller C 3rd, Chardkoff L, Wilson L.

J Am Coll Surg. 2001 Apr;192(4):453-8.

PMID:
11294401
[PubMed - indexed for MEDLINE]
17.

Outcomes of sentinel lymph node dissection alone vs. axillary lymph node dissection in early stage invasive lobular carcinoma: a retrospective study of the surveillance, epidemiology and end results (SEER) database.

Wang J, Mittendorf EA, Sahin AA, Yi M, Caudle A, Hunt KK, Wu Y.

PLoS One. 2014 Feb 25;9(2):e89778. doi: 10.1371/journal.pone.0089778. eCollection 2014.

PMID:
24587029
[PubMed - indexed for MEDLINE]
Free PMC Article
18.

Predictors of completion axillary lymph node dissection in patients with immunohistochemical metastases to the sentinel lymph node in breast cancer.

Pugliese MS, Karam AK, Hsu M, Stempel MM, Patil SM, Ho AY, Traina TA, Van Zee KJ, Cody HS 3rd, Morrow M, Gemignani ML.

Ann Surg Oncol. 2010 Apr;17(4):1063-8. doi: 10.1245/s10434-009-0834-5. Epub 2009 Dec 22.

PMID:
20033325
[PubMed - indexed for MEDLINE]
19.

Sentinel lymph node dissection only versus complete axillary lymph node dissection in early invasive breast cancer: a systematic review and meta-analysis.

Glechner A, Wöckel A, Gartlehner G, Thaler K, Strobelberger M, Griebler U, Kreienberg R.

Eur J Cancer. 2013 Mar;49(4):812-25. doi: 10.1016/j.ejca.2012.09.010. Epub 2012 Oct 17. Review.

PMID:
23084155
[PubMed - indexed for MEDLINE]
20.

Complication rates in patients with negative axillary nodes 10 years after local breast radiotherapy after either sentinel lymph node dissection or axillary clearance.

Wernicke AG, Shamis M, Sidhu KK, Turner BC, Goltser Y, Khan I, Christos PJ, Komarnicky-Kocher LT.

Am J Clin Oncol. 2013 Feb;36(1):12-9. doi: 10.1097/COC.0b013e3182354bda.

PMID:
22134519
[PubMed - indexed for MEDLINE]
Free PMC Article
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk